CIK 0001818331
- Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851966622
- Phone
- +1 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- 4 Option exercise Executive Chairman acquired 67,780 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 11,734 shares at $2.16 ($25,338)
- 4 Open-market sale Chief Transformation Officer sold 1,700 shares at $2.16 ($3,671)
- 4 Open-market sale Chief Financial Officer sold 2,948 shares at $2.16 ($6,366)
- 4 Open-market sale Chief Executive Officer sold 3,673 shares at $1.61 ($5,915)
- 4 Open-market sale Chief Transformation Officer sold 850 shares at $1.61 ($1,369)
- 4 Open-market sale Chief Financial Officer sold 908 shares at $1.61 ($1,462)
- 4 Open-market sale Chief Financial Officer sold 270 shares at $1.77 ($478)
- 4 Open-market buy Executive Chairman bought 114,742 shares at an average $1.41 ($161,368)
- 4 Open-market sale Director sold 883,742 shares at $1.29 ($1,140,027)
- 4 Open-market buy Director bought 10,000 shares at $1.49 ($14,889)
- 4 Open-market sale Chief Transformation Officer sold 164 shares at $3.44 ($564)
- 4 Open-market sale Executive Chairman sold 42 shares at $3.19 ($134)
- 4 Option exercise Executive Chairman acquired 129 shares (option exercise)
- 4 Option exercise Director acquired 129 shares (option exercise)
- 4 Open-market sale Chief Transformation Officer sold 85 shares at $3.56 ($303)
- 4 Open-market sale Chief Executive Officer sold 10,752 shares at $4.16 ($44,749)
- 4 Open-market sale Chief Transformation Officer sold 1,580 shares at $4.16 ($6,575)
- 4 Open-market sale Chief Financial Officer sold 2,742 shares at $4.16 ($11,409)
- 4 Open-market sale Chief Executive Officer sold 2,675 shares at $4.62 ($12,369)
Page 10 of 22 · 438 filings